March 7, 2024
(Reuters) -Boehringer Ingelheim will cap out-of-pocket costs for the company’s inhaler products for a chronic lung disease and asthma at $35 per month starting June 1, […]
March 7, 2024
LONDON (Reuters) – Sexually transmitted infections surged across Europe in 2022, with reported cases of gonorrhoea jumping by nearly a half, the European Centre for Disease […]
March 7, 2024
WEST PALM BEACH, FLORIDA — When evaluated at 3 or 12 months, serum neurofilament light chain (sNfL) levels were predictive of new or enlarging T2 lesions […]
March 7, 2024
West Palm Beach, Florida — In an interim analysis of an extension study, intrathecal injection of autologous bone marrow–derived mesenchymal stem cells (MSCs) has been associated […]
March 7, 2024
Ob/gyns working with data scientists at Cedars-Sinai Medical Center in Los Angeles have developed an algorithm that can help predict which patients are at an increased […]
March 7, 2024
Change Healthcare, which suffered a ransomware attack last month cutting providers off from payer reimbursements, is offering doctors a temporary loan program to tide them over […]
March 7, 2024
West Palm Beach, Florida — Top-line results of two phase 3 trials evaluating the Bruton’s tyrosine kinase (BTK) inhibitor evobrutinib for the treatment of multiple sclerosis […]
March 7, 2024
PARIS — Higher education and research face a cut of €900 million as part of the €10 billion budget savings demanded by the French Ministry of […]
March 7, 2024
The US Food and Drug Administration has expanded the indication of inotuzumab ozogamicin (Besponsa, Pfizer) to include children aged ≥ 1 year with relapsed or refractory […]
Prev page
123456789101112131415161718192021222324252627282930313233343536373839404142434445464748495051525354555657585960616263646566676869707172737475767778798081828384858687888990919293949596979899100101102103104105106107108109110111112113114115116117118119120121122123124125126127128129130131132133134135136137138139140141142143144145146147148149150151152153154155156157158159160161162163164165166167168169170171172173174175176177178179180181182183184185186187188189190191192193194195196197198199200201202203204205206207208209210211212213214215216217218219220221222223224225226227228229230231232233234235236237238239240241242243244245246247248249250251252253254255256257258259260261262263264265266267268269270271272273274275276277278279280281282283284285286287288289290291292293294295296297298299300301302303304305306307308309310311312313314315316317318319320321322323324325326327328329330331332333334335336337338339340341342343344345346347348349350351352353354355356357358359360361362363364365366367368369370371372373374375376377378379380381382383384385386387388389390391392393394395396397398399400401402403404405406407408409410411412413414415416417418419420421422423424425426427428429430431432433434435436437438439440441442443444445446447448449450451452453454455456457458459460461462463464465466467468469470471472473474475476477478479480481482483484485486487488489490491492493494495496497498499500501502503504505506507508509510511512513514515516517518519520521522523524525526527528529530531532533534535536537538539540541542543544545546547548549550551552553554555556557558559560561562563564565566567568569570571572573574575576577578579580581582583584585586587588589590591592593594595596597598599600601602603604605606607608609610611612613614615616617618619620621622623624625626627628629630631632633634635636637638639640641642643644645646647648649650651652653654655656657658659660661662663664665666667668669670671672673674
Next page